These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31051410)
1. The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events. Muendlein A; Leiherer A; Saely C; Ebner J; Geiger K; Brandtner EM; Vonbank A; Fraunberger P; Drexel H Atherosclerosis; 2019 Jul; 286():1-6. PubMed ID: 31051410 [TBL] [Abstract][Full Text] [Related]
2. Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography. Muendlein A; Leiherer A; Saely C; Ebner J; Geiger K; Brandtner EM; Vonbank A; Fraunberger P; Drexel H Data Brief; 2019 Aug; 25():104109. PubMed ID: 31334311 [TBL] [Abstract][Full Text] [Related]
3. Association of C1q/TNF-related protein-1 (CTRP1) serum levels with coronary artery disease. Shen L; Wang S; Ling Y; Liang W J Int Med Res; 2019 Jun; 47(6):2571-2579. PubMed ID: 31081425 [TBL] [Abstract][Full Text] [Related]
4. Association of circulating C1q/TNF-related protein 1 levels with coronary artery disease in men. Yuasa D; Ohashi K; Shibata R; Takeshita K; Kikuchi R; Takahashi R; Kataoka Y; Miyabe M; Joki Y; Kambara T; Uemura Y; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Ito M; Ikeda N; Murohara T; Ouchi N PLoS One; 2014; 9(6):e99846. PubMed ID: 24945145 [TBL] [Abstract][Full Text] [Related]
5. C1q/TNF-related Protein 1, a Multifunctional Adipokine: An Overview of Current Data. Janowska JD Am J Med Sci; 2020 Sep; 360(3):222-228. PubMed ID: 32591091 [TBL] [Abstract][Full Text] [Related]
6. Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1. Barbieri D; Goicoechea M; Sánchez-Niño MD; Ortiz A; Verde E; Verdalles U; Pérez de José A; Delgado A; Hurtado E; Sánchez-Cámara L; Lopez-Lazareno N; García-Prieto A; Luño J Clin Kidney J; 2019 Jun; 12(3):420-426. PubMed ID: 31198543 [TBL] [Abstract][Full Text] [Related]
7. C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. Lu L; Zhang RY; Wang XQ; Liu ZH; Shen Y; Ding FH; Meng H; Wang LJ; Yan XX; Yang K; Wang HB; Pu LJ; Zhang Q; Chen QJ; De Caterina R; Shen WF Eur Heart J; 2016 Jun; 37(22):1762-71. PubMed ID: 26705391 [TBL] [Abstract][Full Text] [Related]
8. Association between adiponectin production in coronary circulation and future cardiovascular events in patients with coronary artery disease. Kawagoe J; Ishikawa T; Iwakiri H; Date H; Imamura T; Kitamura K Int Heart J; 2014; 55(3):239-43. PubMed ID: 24806386 [TBL] [Abstract][Full Text] [Related]
9. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896 [TBL] [Abstract][Full Text] [Related]
10. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes. Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150 [TBL] [Abstract][Full Text] [Related]
11. S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease. Saito T; Hojo Y; Ogoyama Y; Hirose M; Ikemoto T; Katsuki T; Shimada K; Kario K Circ J; 2012; 76(11):2647-52. PubMed ID: 22786469 [TBL] [Abstract][Full Text] [Related]
12. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Kip KE; Marroquin OC; Kelley DE; Johnson BD; Kelsey SF; Shaw LJ; Rogers WJ; Reis SE Circulation; 2004 Feb; 109(6):706-13. PubMed ID: 14970104 [TBL] [Abstract][Full Text] [Related]
13. Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: a pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Chalupova L; Zakovska A; Adamcova K Clin Biochem; 2013 Jan; 46(1-2):73-8. PubMed ID: 23000311 [TBL] [Abstract][Full Text] [Related]
14. Circulating adiponectin level is associated with major adverse cardiovascular events in type 2 diabetic patients with coronary artery disease. Hung WC; Wang CP; Lu LF; Yu TH; Chiu CA; Chung FM; Chen HJ; Houng JY; Shin SJ; Lee YJ Endocr J; 2010; 57(9):793-802. PubMed ID: 20818134 [TBL] [Abstract][Full Text] [Related]
15. Loss of CTRP1 disrupts glucose and lipid homeostasis. Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D and prognosis in acute myocardial infarction. Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169 [TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791 [TBL] [Abstract][Full Text] [Related]
18. CTRP1: A novel player in cardiovascular and metabolic diseases. Wang Y; Li H; Yu XH; Tang CK Cytokine; 2023 Apr; 164():156162. PubMed ID: 36812667 [TBL] [Abstract][Full Text] [Related]
19. 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease. Schaan BD; Quadros AS; Sarmento-Leite R; De Lucca G; Bender A; Bertoluci M Cardiovasc Diabetol; 2007 Jul; 6():19. PubMed ID: 17651487 [TBL] [Abstract][Full Text] [Related]